TrialJapanese journal of clinical oncology2011

Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1.

Taiji Tsukamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.